Get the Stockscreener App
112.71
8.23%
-10.09
Illumina Inc stock is traded at $112.71, with a volume of 3.12M.
It is down -8.23% in the last 24 hours and down -18.97% over the past month.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
See More
Previous Close:
$122.80
Open:
$111.3
24h Volume:
3.12M
Relative Volume:
1.57
Market Cap:
$19.48B
Revenue:
$4.39B
Net Income/Loss:
$-1.58B
P/E Ratio:
-11.32
EPS:
-9.96
Net Cash Flow:
$546.00M
1W Performance:
-15.10%
1M Performance:
-18.97%
6M Performance:
-6.94%
1Y Performance:
-21.16%
1-Day Range:
$108.81
$115.16
1-Week Range:
$108.81
$132.41
52-Week Range:
$100.08
$156.66
Illumina Inc Stock (ILMN) Company Profile
Name
Illumina Inc
Sector
Industry
Phone
(858) 202-4500
Address
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
112.69 | 19.48B | 4.39B | -1.58B | 546.00M | -9.96 |
|
TMO
Thermo Fisher Scientific Inc
|
569.82 | 219.06B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
206.94 | 151.02B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
145.24 | 42.12B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
457.78 | 37.71B | 3.84B | 866.24M | 792.60M | 10.37 |
|
IQV
Iqvia Holdings Inc
|
207.23 | 36.97B | 15.32B | 1.41B | 1.96B | 7.62 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Nov-12-24 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Aug-28-24 | Upgrade | Argus | Hold → Buy |
| Aug-16-24 | Upgrade | Daiwa Securities | Neutral → Buy |
| Aug-14-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-14-24 | Upgrade | TD Cowen | Hold → Buy |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jan-04-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Dec-18-23 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Dec-15-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-14-23 | Initiated | Stephens | Overweight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-11-23 | Upgrade | Citigroup | Sell → Neutral |
| Nov-10-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-28-23 | Initiated | Bernstein | Underperform |
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-25-23 | Downgrade | Argus | Buy → Hold |
| Jan-05-23 | Initiated | Scotiabank | Sector Perform |
| Dec-12-22 | Downgrade | Citigroup | Neutral → Sell |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-04-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Sep-28-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Jul-13-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-18-22 | Upgrade | Stifel | Hold → Buy |
| Jan-11-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-07-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jun-01-21 | Upgrade | Evercore ISI | Underperform → In-line |
| Mar-31-21 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Mar-31-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-03-21 | Initiated | Barclays | Underweight |
| Dec-22-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-17-20 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-13-20 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-29-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-22-20 | Downgrade | Stifel | Buy → Hold |
| Sep-22-20 | Downgrade | UBS | Buy → Neutral |
| Sep-21-20 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-21-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-09-20 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-07-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Aug-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-07-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-24-20 | Downgrade | Citigroup | Buy → Neutral |
| Apr-21-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-15-19 | Initiated | Stifel | Buy |
| Oct-25-19 | Initiated | Guggenheim | Buy |
View All
Illumina Inc Stock (ILMN) Latest News
TD Cowen cuts rating on Illumina stock to hold - Investing.com
Illumina, Inc. (NASDAQ:ILMN) Q4 2024 Earnings Call Transcript - Insider Monkey
Yousif Capital Management LLC Reduces Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Multiomics Market 2024 Size, Global Report till 2031 | Thermo Fisher Scientific Inc., Illumina, Inc., Becton Dickinson - openPR
Illumina’s 2024 Financial Performance and 2025 Outlook - TipRanks
Illumina (ILMN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Illumina (ILMN) Q4 Earnings Miss Estimates - MSN
Janney Montgomery Scott LLC Purchases 2,130 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Earnings call transcript: Illumina Q4 2024 beats EPS, stock falls - Investing.com
Illumina: Q4 Earnings Snapshot - The Washington Post
Illumina Faces Challenges With Revenue Outlook Missing The Mark - Finimize
Illumina stock slides amid Q4 report, possible China sanctions - Seeking Alpha
Illumina (NASDAQ:ILMN) Beats Q4 Sales Targets By Stock Story - Investing.com Canada
Illumina: Q4 Earnings Snapshot -February 06, 2025 at 05:10 pm EST - Marketscreener.com
Illumina (NASDAQ:ILMN) Beats Q4 Sales Targets - Yahoo Finance
Illumina forecasts 2025 revenue largely below estimates - Reuters
Illumina earnings beat by $0.03, revenue topped estimates - Investing.com Canada
Illumina, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 29, 2024 - Marketscreener.com
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2024 - PR Newswire
ILMN: 3 Genomics Stocks Unlocking the Future of Medicine - StockNews.com
DNA Microarray Market to Grow with Leading Key PlayersThermo - openPR
abrdn plc Sells 124,654 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Blue Trust Inc. Acquires 154 Shares of Illumina, Inc. (NASDAQ:ILMN) - Defense World
Illumina (ILMN) to Release Quarterly Earnings on Thursday - MarketBeat
CN MOC: Measures Will Be Taken Against PVH, Illumina Based on Relevant Laws - AASTOCKS.com
RNA Sequencing Market 2024: Future Scope, Industry Growth, - openPR
San Diego’s Illumina placed on China’s ‘unreliable entity list’ following Trump tariffs - The San Diego Union-Tribune
Here's How Much $100 Invested In Illumina 20 Years Ago Would Be Worth Today - Benzinga
Amazon, Take-Two, Illumina set to report earnings Thursday - Investing.com
Amazon, Take-Two, Illumina set to report earnings Thursday By Investing.com - Investing.com Canada
Illumina placed on China’s ‘unreliable entity’ list - BioPharma Dive
Illumina placed on China’s unreliable entity list - MedTech Dive
Illumina (ILMN) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
Hold Rating for Illumina Amid Geopolitical and Competitive Challenges - TipRanks
China Signals Rationale Behind Its Antitrust Probe into Google and Sanctions Against PVH and Illumina - substack.com
Page 7 | ILLUMINA INC Trade Ideas — XETR:ILU - TradingView
Cathie Wood's ARK buys Illumina stock, trims Palantir - Investing.com
Why Illumina Stock Plummeted Today - MSN
China blacklists Illumina as part of US tariffs counter - BioWorld Online
Trump Confirms Maximum Economic Pressure On Iran, Calls China's Tariff Retaliation 'Fine' - Benzinga
China adds PVH Corp. and Illumina to unreliable entity list - Dimsum Daily
Illumina (ILMN) Stock Trades Down, Here Is Why - Barchart
PVH, Illumina Added to China's Unreliable Companies List by Ministry -February 04, 2025 at 02:21 pm EST - Marketscreener.com
China Adds Calvin Klein Owner and Illumina to Blacklist - MSN
PVH, Illumina shares slide after China targets companies - MSN
Illumina (ILMN) Stock Trades Down, Here Is Why By Stock Story - Investing.com Canada
Illumina, PVH shares drop as China threatens companies with sanctions - Reuters
PVH, Illumina Added to China's Unreliable Companies List -February 04, 2025 at 11:53 am EST - Marketscreener.com
Stocks to Watch Tuesday: Illumina, PVH, Palantir, Merck - The Wall Street Journal
Illumina Stock Tumbles Nearly 5% Overnight On Robinhood As China Adds ILMN, Calvin Klein Owner PVH To 'Unreliable Entities List' Amid Trade War With US - MSN
Calvin Klein Parent PVH, Illumina Put on China's 'Unreliable Entity' List - Yahoo Finance
Illumina Inc Stock (ILMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.50%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):